Register to view the archived recording here.
Illumina Says 'Significant Growth' in Sequencing Demand Drove 12-Percent Rise in Q4 Revenue
The company said it is in discussions with several large genome centers about replacing their Genome Analyzers with the newly launched HiSeq 2000, but stressed it is premature to forecast how many customers will opt to trade up.
New to GenomeWeb? Register here quickly.